A research team at the University of Cologne has made a significant breakthrough in understanding the role of the tau protein ...

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...

A vast search of natural diversity has led scientists at MIT’s McGovern Institute and the Broad Institute of MIT and Harvard ...

The ability to control gene expression across a wide range is crucial for many fields, including bioengineering, disease ...

The Nucleic Acid Isolation and Purification Market is projected to be valued at USD 1,178.6 million in 2025 and is expected to grow at a CAGR of 5.6% from 2025 to 2035, reaching USD 2,038.1 million by ...

CAMBRIDGE, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

LEWES, Del., Feb. 26, 2025 /PRNewswire/ -- The Global CRISPR Market Size is projected to grow at a CAGR of 15.85% from 2026 to 2032, according to a new report published by Verified Market Research®.

ERS Genomics ('ERS'), which was established to provide broad access to the foundational CRISPR/Cas9 intellectual property ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced the appointment of Rachel Jones as Chief Commercial Officer. With over 25 years of experience in molecular ...

Cancer cells thrive in an environment deprived of oxygen and nutrients, adapting to survive and grow. Unlike normal cells, ...